MST NEWS

Korea-Japan joint new drug development and natural ingredient consulta…

페이지 정보

작성자 ㈜MST 조회881 View 작성일 18-11-28 09:53

본문

Korea-Japan joint new drug development and natural ingredient consultation. 


In November 2018, we MST(KOREA) CO., LTD.(CEO Woong-Sig Moon·www.BioCleanAct.com·BrandName: BioCleanAct™held an invitation to invite buyers in Tokyo, Japan.


Consultation contents:
Korea-Japan Natural Products New Drug Development Agreement
Consultation on the sales of natural products in Japan
We hold buyer meeting of functional raw materials derived from natural materials. 


e455a2034b6f86b6e8f0ae6169ca1435_1578530461_9463.gif
e455a2034b6f86b6e8f0ae6169ca1435_1578530462_3533.gif
e455a2034b6f86b6e8f0ae6169ca1435_1578530462_456.gif

 CEO/Chairman Woong-Sig Moon,right